Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

72.18
-0.7800-1.07%
Post-market: 72.180.00000.00%19:30 EDT
Volume:309.51K
Turnover:22.34M
Market Cap:1.66B
PE:15.90
High:73.27
Open:73.16
Low:71.73
Close:72.96
52wk High:97.00
52wk Low:69.58
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.89
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.78
PE(LYR):21.74

Loading ...

ANI Pharma General Counsel Meredith Cook sells 500 shares worth $39,080

Reuters
·
May 14

ANI Pharma releases corporate presentation outlining rare-disease shift, 2026 revenue outlook $1.1-$1.14 billion

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Definitive Healthcare Corp (DH) and Denali Therapeutics (DNLI)

TIPRANKS
·
May 11

Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

ANI Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $105 From $111

THOMSON REUTERS
·
May 11

ANI Pharmaceuticals (ANIP) Profit Swing And One Off Gain Test Bullish Narratives

Simply Wall St.
·
May 09

H.C. Wainwright Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 09

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Update: ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook

MT Newswires Live
·
May 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 to $9.69, vs. FactSet Est of $9.07

MT Newswires Live
·
May 08

Stock Track | ANI Pharmaceuticals Soars 5.35% in Pre-market on Strong Earnings Beat, Raised Guidance and $100M Buyback

Stock Track
·
May 08

ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million

Reuters
·
May 08

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3

Reuters
·
May 08

ANI Pharmaceuticals Q1 EPS USD 1.28

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Q1 Adjusted Ebitda USD 63 Million

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Inc: $100 Mln Share Repurchase Program Authorized by Board of Directors

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08